Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Screening Scientist

Screening Scientist

Charline Giroud

Screening Scientist

Charline Giroud graduated with a PhD degree in Biochemistry, Cellular and Molecular Biology, specialized in Virology, from the School of Medicine of Montpelier, France (2012). She studied the role of cAMP-dependent protein kinase (PKA) incorporated in HIV-1 particle, in early steps of the virus life cycle and showed that PKA acts as a cofactor of reverse transcription initiation.

She worked at the Department of Paediatric Infectious Diseases at the School of Medicine of Emory University of Atlanta, USA (2013) as a postdoctoral fellow. Using high throughput screening strategy combined to cell-based assay development, she discovered and characterized new HIV-1 and Ebola virus entry inhibitors for HIV-1 and Ebola virus entry. She started in the assay development and screening team in May 2017.

Recent publications

More publications